Methylene blue is a blue dye and prescription drug whose FDA-approved use is treating acquired methemoglobinemia, a blood disorder in which hemoglobin cannot carry oxygen properly.1 Small studies in healthy adults found that a single low dose changed brain activity on MRI and improved one memory measure.3,4 Its label carries a boxed warning for serotonin syndrome with SSRIs, SNRIs, MAOIs and opioids.1 If you are considering it for focus or mood, the first step is a physician's review of every medication you take.
What Methylene Blue Is
Methylene blue is a water-soluble thiazine dye that acts as an oxidation-reduction agent, meaning it can accept and pass on electrons.1 That chemistry is the basis of its medical use. It is also why the drug turns urine blue, because the dye passes freely into the urine.1
Researchers describe methylene blue USP as an FDA-grandfathered drug used in clinics for methemoglobinemia, carbon monoxide poisoning and cyanide poisoning.4 The approved product, PROVAYBLUE, is an injection given into a vein, with an initial U.S. approval in 2016.1
Most interest outside the hospital traces to a small set of brain-imaging studies.3,4 Before you weigh those claims, you need to know what the approved use is and what the label warns about.
The FDA-Approved Use in Methemoglobinemia
The PROVAYBLUE label lists one indication: treatment of children and adults with acquired methemoglobinemia.1 In this condition, the iron inside hemoglobin shifts to a form that cannot carry oxygen.
The label explains the mechanism step by step.1 An enzyme called NADPH reductase converts methylene blue to leucomethylene blue inside the body. Leucomethylene blue then converts the iron back to the form found in normal hemoglobin, which restores oxygen transport.1
Every other use, including memory, focus, mood, energy and longevity, is off-label. If a product or clinic offers you methylene blue for those goals, you are looking at a use the FDA has not reviewed. Your physician can tell you what evidence exists for your specific goal.
Hospital Uses Beyond Methemoglobinemia
Clinicians also use methylene blue in septic shock, where blood pressure stays low despite standard drugs. A 2024 meta-analysis pooled six randomized trials with 302 patients.2 On low-certainty evidence, methylene blue may reduce short-term mortality, time on blood pressure drugs and hospital length of stay, with no increase in adverse events.2
These are intensive care results in critically ill adults. They show that methylene blue is a hospital drug with measurable effects on blood pressure. They do not tell you what it would do for you at home, so read them as background when you see wellness claims that cite them.
Memory and Attention Studies in Healthy Adults
The best-known human brain studies come from one research group. In a 2016 randomized, placebo-controlled trial, 26 adults aged 22 to 62 had functional MRI scans before and one hour after a low dose of methylene blue or placebo.3
Methylene blue increased brain activity during tasks of sustained attention and short-term memory.3 It was also associated with a 7% increase in correct responses during memory retrieval.3 A related study found stronger resting connections between brain regions linked to perception and memory after a single oral dose.4
These results are early. Each study gave one dose and measured the effect an hour later, in small groups of healthy volunteers. The authors themselves called for further investigation in healthy and disease populations.4 Neither study tested repeated use over weeks, or men who came in with brain fog.
Practical takeaway: if focus or memory is your concern, a physician can look for the cause before you consider a drug tested only as a single dose in healthy volunteers. The brain fog causes and treatment page covers the common drivers a physician checks, and nootropics covers the wider category of cognitive enhancers.
Mood and Alzheimer's Disease Research
Methylene blue has been tested in two other brain conditions, with mixed results. Each trial gives you a narrow signal in a specific population.
In bipolar disorder, a six-month crossover trial enrolled 37 people already taking lamotrigine.5 Adding methylene blue improved residual depression and anxiety symptoms, while effects on cognitive symptoms did not reach statistical significance.5 Side effects were mild and transient.5 This was an add-on to an existing treatment in one diagnosis, so it does not establish methylene blue as an antidepressant for you.
In Alzheimer's disease, a large phase 3 trial tested LMTM, a stable reduced form of the same molecule designed to block tau protein clumping.6 It randomized 891 people with mild to moderate disease. The primary analysis was negative and did not suggest benefit as an add-on treatment.6
If mood is part of why you are asking, raise it directly with your physician. That conversation changes the safety picture, because the medicines most often used for depression are the ones the label warns against.
Methylene Blue as a Supplement
Methylene blue is sold online for focus, energy and weight loss. The FDA-approved product is an intravenous drug for methemoglobinemia, and the memory data come from single-dose studies in small groups of healthy adults.1,3,4
The label's interaction warning covers the molecule itself. Serotonin syndrome has been reported with "methylene blue class products," and most reports involved serotonergic drugs.1 A bottle sold as a supplement contains the same dye, so the same caution applies to you whichever way it is sold.
If you are comparing products, the more useful question is whether methylene blue suits you at all. A physician can answer that with your medication list and labs, and that answer comes before any choice of product.
The Serotonin Syndrome Warning and Other Safety Facts
The boxed warning is the most serious statement on the label. Methylene blue may cause serious or fatal serotonin syndrome when combined with serotonergic drugs and opioids.1 The label says to avoid using it with SSRIs, SNRIs, MAOIs and opioids.1 Dextromethorphan, a common cough suppressant, may also raise the risk.1
Serotonin syndrome can cause agitation, a fast heart rate, high body temperature, tremor, muscle rigidity and seizures.1 The label adds several other facts that matter for you:1
- G6PD deficiency: methylene blue is contraindicated, because it can cause severe hemolytic anemia, the breakdown of red blood cells.
- Allergy to thiazine dyes: severe hypersensitivity is a contraindication.
- Pulse oximeter readings: methylene blue in the blood can make oxygen readings appear lower than they are.
- Driving: it may cause confusion, dizziness and vision disturbances.
- Urine tests: the blue dye can interfere with urine tests that rely on a blue indicator.
Methylene blue has a half-life of about 24 hours, so it stays in your body after the last dose.1 The label advises against taking serotonergic drugs within 72 hours after the last dose.1 If you take an antidepressant, bring the full list to your physician before anything else happens.
How a Physician Decides Whether Methylene Blue Fits You
A physician starts with your medication list, because the boxed warning makes that the deciding factor. Antidepressants, opioid pain medicines and dextromethorphan each raise the serotonin syndrome risk.1
G6PD status matters next, since deficiency is a contraindication.1 Then comes your goal. If the goal is sharper focus or more energy, a physician looks at the measurable drivers first. Hormones, thyroid function, sleep and nutrient status each have a lab or a history that can be checked.
You and your physician should agree on what improvement looks like before you start any off-label medicine. A clear measure gives you a fair test and tells you and your physician when to stop.
The Opt Take on Methylene Blue
Methylene blue is a medication with one approved use and a serious interaction warning, so the decision belongs with a physician who knows every drug you take. At Opt Health, your existing conditions and current medications are reviewed at your initial consultation. That review covers any antidepressant or opioid you take before a prescription is considered.
Your blood panel covers 55+ biomarkers spanning hormones, inflammation, cardiovascular risk and more. When the goal is energy, an Opt Health physician examines cortisol, insulin, sex hormones and thyroid, along with sleep apnea, gut problems and nutritional deficiencies. Finding the measurable cause is the starting point of your plan.
A physician reads your results with you 1:1 and builds a plan that can include prescriptions, peptides and supplements. Labs and a physician consultation repeat every 3 to 4 months, so your plan is judged against your own numbers and adjusted on what changed.
Get started: Begin with Opt Health, where a physician reads your labs, builds your plan, and adjusts it over the loop.
Frequently Asked Questions
Methylene blue's FDA-approved use is treating acquired methemoglobinemia.1 Hospitals also use it in septic shock, where low-certainty evidence suggests it may reduce short-term mortality.2 Small single-dose studies in healthy adults found changes in brain activity and one memory measure.3,4 For focus or energy, your physician can first check the measurable causes behind your symptoms.
In methemoglobinemia, the body converts methylene blue to leucomethylene blue, which returns the iron in hemoglobin to its normal oxygen-carrying form.1 The way it might affect the brain is still being studied. The human imaging trials found changes in brain activity after one dose. They do not tell you whether repeated use would give you a lasting effect.3,4
Methylene blue is used because it reverses the chemical change that defines the condition.1 In methemoglobinemia, hemoglobin iron is in a form that cannot carry oxygen. Leucomethylene blue reduces that iron back to the normal form, and PROVAYBLUE is FDA-approved for this purpose in children and adults.1
The research studies gave methylene blue by mouth under study supervision.3,4 Whether it is appropriate for you is a prescribing decision. The label's boxed warning covers SSRIs, SNRIs, MAOIs and opioids, and G6PD deficiency is a contraindication.1 Your physician needs your full medication list before any decision about it.
Methylene blue has no established general health benefit. Its proven value is in treating methemoglobinemia, with supporting evidence in septic shock.1,2 The brain findings come from single doses in small healthy groups.3,4 If you want better focus or energy, a physician can measure the drivers of your symptoms and build a plan around them.
Methylene blue starts with a review of every medication you take and what your labs show. An Opt Health membership pairs 55+ biomarkers with a 1:1 physician review, then repeats labs and a physician consultation every 3 to 4 months.
References
- American Regent, Inc. PROVAYBLUE (methylene blue) injection, USP, for intravenous use. Prescribing information. DailyMed. Published June 12, 2025. Accessed October 14, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4f6848e5-35ed-4046-b13c-3032b5ba3232
- Fernando SM et al. Methylene blue in septic shock: a systematic review and meta-analysis. Crit Care Explor. 2024;6(7):e1110. https://pubmed.ncbi.nlm.nih.gov/38904978/
- Rodriguez P et al. Multimodal randomized functional MR imaging of the effects of methylene blue in the human brain. Radiology. 2016;281(2):516-526. https://pubmed.ncbi.nlm.nih.gov/27351678/
- Rodriguez P et al. Methylene blue modulates functional connectivity in the human brain. Brain Imaging Behav. 2017;11(3):640-648. https://pubmed.ncbi.nlm.nih.gov/26961091/
- Alda M et al. Methylene blue treatment for residual symptoms of bipolar disorder: randomised crossover study. Br J Psychiatry. 2017;210(1):54-60. https://pubmed.ncbi.nlm.nih.gov/27284082/
- Gauthier S et al. Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial. Lancet. 2016;388(10062):2873-2884. https://pubmed.ncbi.nlm.nih.gov/27863809/
This content is for informational purposes and does not replace evaluation, diagnosis, or treatment by a qualified medical professional.
This article is part of our guide to longevity. See how longevity medicine works at Opt Health.
Start Today
Your health, your terms. Discover how personalized care can transform not just the way you feel, but how you live.